Today, November 4, I sold 25% of my Crocs (CROX) position.
Following the stock’s strong recovery, CROX is now trading approximately 80% above my average purchase cost.
At the current valuation, I decided it made sense to realize some gains and reduce my portfolio exposure. While I still see potential value in the business, the risk-reward balance is less attractive than it was at my original purchase prices.
I continue to hold the remaining 75% of my position.
As usual, for portfolio performance reporting, I’ll use today’s closing share price rather than my actual execution price to maintain consistency across transactions.